GlassScriptPhysician profile
Santosh Desai
NPI 1477852010
$26,011.60
in general payments reported to CMS, 2019-2025
45 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,406 · 2020: $602 · 2021: $824 · 2022: $864 · 2023: $942 · 2024: $3,594 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,084 · Consulting Fee: $5,640 · Travel and Lodging: $3,846 · Honoraria: $3,316 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,410 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,083.78 |
| Consulting Fee | $5,640.00 |
| Travel and Lodging | $3,846.01 |
| Honoraria | $3,316.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,410.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $10,918.79 | 2023-2025 | Coronary Undivided, (7881) US Und, Igt Devices Undivided |
| Penumbra, INC. | $3,650.32 | 2019-2025 | Indigo System |
| Angiodynamics, INC. | $3,232.16 | 2025 | Angiovac, Auryon Laser System 100-120 Vac, Alphavac |
| Boston Scientific Corporation | $1,352.72 | 2019-2025 | General - Tachy, Lux-Dx Insertable Cardiac Monitor, Ingevity+ |
| Abiomed | $1,277.45 | 2019-2025 | Impella |
| Impulse Dynamics (USA) INC. | $787.79 | 2022-2025 | Optimizer, Optimizer |
| Amgen INC. | $460.32 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $443.61 | 2021-2024 | Resolute Onyx, Corevalve Evolut R, Venaseal |
| Medtronic Vascular, INC. | $426.31 | 2019 | |
| Cardiovascular Systems INC. | $389.50 | 2019 | |
| Abbott Laboratories | $335.97 | 2020-2025 | Gallant, Triclip, Mitraclip |
| Novartis Pharmaceuticals Corporation | $316.01 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $277.80 | 2020-2024 | Wainua |
| E.R. Squibb & Sons, L.L.C. | $222.12 | 2022-2025 | Camzyos, Eliquis |
| Terumo Medical Corporation | $216.47 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santosh Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.